M A Brown
- Cancer Research top 5%
- Protease and Inhibitor Mechanisms 3
- Biotechnology top 2%
- Oncology top 5%
- Peptidase Inhibition and Analysis 10
- Hematology top 5%
- Cell Biology top 5%
-
- Biochemical and Structural Characterization 4
-
- Neuropeptides and Animal Physiology 4
-
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 3
-
- Adenosine and Purinergic Signaling 2
-
- Blood properties and coagulation 1
-
- Diagnosis and treatment of tuberculosis 1
- Co-authors
- A. John BarrettA A KembhaviChristopher G. KnightKazunori HanadaHeidrun KirschkeMotoki TamaiNeil D. RawlingsDavid C. Sunter
- Cited by
- Cancer ResearchBiotechnologyOncology
- Journals
- Biochemical Journal (9 papers)Biopharmaceutics & Drug Disposition (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- United StatesSwedenGermany
In The Last Decade
M A Brown
16 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Cancer Research 582
- Biotechnology 205
- Oncology 618
- Hematology 243
- Cell Biology 347
Countries citing papers authored by M A Brown
This map shows the geographic impact of M A Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M A Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M A Brown more than expected).
Fields of papers citing papers by M A Brown
This network shows the impact of papers produced by M A Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M A Brown. The network helps show where M A Brown may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M A Brown, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 310 | |
| 2 | 1995 | 9 | |
| 3 | 1995 | 75 | |
| 4 | 1995 | 5 | |
| 5 | 1993 | 72 | |
| 6 | 1993 | 55 | |
| 7 | 1992 | 8 | |
| 8 | 1990 | 43 | |
| 9 | 1989 | 30 | |
| 10 | 1988 | 21 | |
| 11 | 1987 | 38 | |
| 12 | 1986 | 76 | |
| 13 | 1984 | 49 | |
| 14 | 1983 | 276 | |
| 15 | L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and Lbreakdown → | 1982 | 934 |
| 16 | The electrophoretically ‘slow’ and ‘fast’ forms of the α2-macroglobulin moleculebreakdown → | 1979 | 500 |
About M A Brown
M A Brown is a scholar working on Physiology, Oncology, Genetics, Cellular and Molecular Neuroscience and Sensory Systems, having authored 16 papers that have together received 2.5k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (10 papers), Biochemical and Structural Characterization (4 papers), Neuropeptides and Animal Physiology (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Protease and Inhibitor Mechanisms (3 papers), Adenosine and Purinergic Signaling (2 papers), Blood properties and coagulation (1 paper) and Diagnosis and treatment of tuberculosis (1 paper). The work is most often cited by research in Cancer Research (582 citations), Biotechnology (205 citations), Oncology (618 citations), Hematology (243 citations) and Cell Biology (347 citations). M A Brown has collaborated with scholars based in United States, Sweden and Germany. Frequent co-authors include A. John Barrett, A A Kembhavi, Christopher G. Knight, Kazunori Hanada, Heidrun Kirschke, Motoki Tamai, Neil D. Rawlings, David C. Sunter, Martin J.H. Nicklin and Jinq-May Chen. Their work appears in journals such as Biochemical Journal, Biopharmaceutics & Drug Disposition, Journal of Biological Chemistry, Experimental Cell Research and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.